However, the release of the senescence-associated secretory phenotype (SASP) by senescent cancer cells could promote chronic inflammation in the tumor, leading to deleterious consequences.647 The determinants of the extent of senescence induced by CDK4/6 inhibitors are not fully understood. Here, CDK4 is linked to cancer.